by The global oncology molecular diagnostic market size was estimated to be around US$ 2.45 billion in 2023 and is projected to reach US$ 7.71 billion by 2033, indicating a CAGR of 12.20% from 2023 to 2033.
The market research report on the Oncology molecular diagnostic market provides a comprehensive analysis of various key aspects. It includes the definition, classification, and application of Oncology molecular diagnostic products. The report examines the development trends, competitive landscape, and industrial chain structure within the industry. Furthermore, it presents an overview of the industry, analyzes national policies and planning, and offers insights into the latest market dynamics and opportunities at a global level.
Get a Sample: https://www.precedenceresearch.com/sample/3677
Oncology Molecular Diagnostic Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 12.20% |
| Global Market Size in 2023 | USD 2.45 Billion |
| Global Market Size by 2033 | USD 7.71 Billion |
| U.S. Market Size in 2023 | USD 0.70 Billion |
| U.S. Market Size by 2033 | USD 2.25 Billion |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Type, By Technology and By Product |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read More: Nickel Market Size To Attain USD 78.47 Billion By 2033
The report presents the volume and value-based market size for the base year 2022 and forecasts the market’s growth between 2023 and 2032. It estimates market numbers based on product form and application, providing size and forecast for each application segment in both global and regional markets.
Focusing on the global Oncology molecular diagnostic market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the Oncology molecular diagnostic market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.
Regarding production, the report investigates the capacity, production, value, ex-factory price, growth rate, and market share of major manufacturers, regions, and product types. On the consumption side, the report focuses on the regional consumption of Oncology molecular diagnostic products across different countries and applications.
Buyers of the report gain access to verified market figures, including global market size in terms of revenue and volume. The report provides reliable estimations and calculations for global revenue and volume by product type from 2023 to 2032. It also includes accurate figures for production capacity and production by region during the same period.
The research includes product parameters, production processes, cost structures, and data classified by region, technology, and application. Furthermore, it conducts SWOT analysis and investment feasibility studies for new projects.
This in-depth research report offers valuable insights into the Oncology molecular diagnostic market. It employs an objective and fair approach to analyze industry trends, supporting customer competition analysis, development planning, and investment decision-making. The project received support and assistance from technicians and marketing personnel across various links in the industry chain.
The competitive landscape section of the report provides detailed information on Oncology molecular diagnostic market competitors. It includes company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites, production capacities, strengths and weaknesses, product launches, product range, and application dominance. However, the data points provided only focus on the companies’ activities related to the Oncology molecular diagnostic market.
Prominent players in the market are expected to face tough competition from new entrants. Key players are targeting acquisitions of startup companies to maintain their dominance.
Reasons to Purchase this Report:
- Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
- In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
- Market size in USD million and volume in million units provided for each segment and sub-segment.
- Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
- Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.
Oncology Molecular Diagnostic Market Companies
- Roche Diagnostics
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Qiagen N.V.
- Bio-Rad Laboratories, Inc.
- Genomic Health, Inc.
- Myriad Genetics, Inc.
- Agilent Technologies, Inc.
- Siemens Healthineers
- Danaher Corporation (Cepheid)
- Sysmex Corporation
- Hologic, Inc.
- Guardant Health, Inc.
- Foundation Medicine, Inc.
Segments Covered in the Report:
By Type
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Liver Cancer
- Lung Cancer
- Blood Cancer
- Kidney Cancer
- Other Cancer
By Technology
- PCR
- In Situ Hybridization
- INAAT
- Chips and Microarrays
- Mass Spectrometry
- Sequencing
- TMA
- Others
By Product
- Instruments
- Reagents
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Oncology Molecular Diagnostic Market
5.1. COVID-19 Landscape: Oncology Molecular Diagnostic Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Oncology Molecular Diagnostic Market, By Type
8.1. Oncology Molecular Diagnostic Market Revenue and Volume, by Type, 2024-2033
8.1.1 Breast Cancer
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Prostate Cancer
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Colorectal Cancer
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Cervical Cancer
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Liver Cancer
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
8.1.6. Lung Cancer
8.1.6.1. Market Revenue and Volume Forecast (2021-2033)
8.1.7. Lung Cancer
8.1.7.1. Market Revenue and Volume Forecast (2021-2033)
8.1.8. Blood Cancer
8.1.8.1. Market Revenue and Volume Forecast (2021-2033)
8.1.9. Kidney Cancer
8.1.9.1. Market Revenue and Volume Forecast (2021-2033)
8.1.10. Other Cancer
8.1.10.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Oncology Molecular Diagnostic Market, By February
9.1. Oncology Molecular Diagnostic Market Revenue and Volume, by February, 2024-2033
9.1.1. Cathode
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Anode
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Electrolyte
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Separator
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
9.1.5. Others
9.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Oncology Molecular Diagnostic Market, By March
10.1. Oncology Molecular Diagnostic Market Revenue and Volume, by March, 2024-2033
10.1.1. Consumer
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Automotive
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Industrial
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Cheese
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1.5. Others
10.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Oncology Molecular Diagnostic Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.1.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.1.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.1.4.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.1.4.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.1.5.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.1.5.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.2.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.4.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.2.4.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.5.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.2.5.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.6.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.2.6.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.7.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.2.7.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.3.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.4.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.3.4.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.5.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.3.5.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.6.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.3.6.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.7.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.3.7.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.4.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.4.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.4.4.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.5.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.4.5.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.6.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.4.6.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.7.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.4.7.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.5.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.5.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.5.4.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.5.4.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.5.5.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.5.5.3. Market Revenue and Volume Forecast, by March (2021-2033)
Chapter 12. Company Profiles
12.1. Roche Diagnostics
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Abbott Laboratories
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Thermo Fisher Scientific Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Illumina, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Qiagen N.V.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Bio-Rad Laboratories, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Genomic Health, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Myriad Genetics, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Agilent Technologies, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Siemens Healthineers
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
